-+ 0.00%
-+ 0.00%
-+ 0.00%

MANNKIND AWARDED BREAKTHROUGH T1D GRANT TO SUPPORT ADVANCEMENT OF INHALE-1ST PEDIATRIC TRIAL OF AFREZZA® IN YOUTH WITH NEWLY-DIAGNOSED T1D

Reuters·06/23/2026 13:06:35

Please log in to view news